Merck’s Ebola Vaccine, A Christmas Gift for the World: Really?

The media is in a tizzy over the recent trial results of Merck’s experimental Ebola vaccine, rVSV-ZEBOV (recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus). “New Ebola Vaccine Gives 100 Percent Protection,” reads a headline in The New York Times.1 The headline in Science Alert sounds even more conclusive… “It’s Official: We Finally Have An Ebola Vaccine That’s Up to 100% Effective.”2 Forbes is positively joyous with its “A Christmas Gift For The World. Ebola Vaccine Is 100% Effective In Early Trial.”

Click this link to read the full story: Merck’s Ebola Vaccine, A Christmas Gift for the World: Really?

Please follow and like us:

Related Post

Leave a Reply